Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Buy
1,185
+3
+0.3% +$1.03K 0.15% 122
2026
Q1
$416K Sell
1,182
-107
-8% -$38.1K 0.16% 113
2025
Q4
$422K Buy
1,289
+115
+10% +$36.5K 0.16% 116
2025
Q3
$331K Sell
1,174
-38
-3% -$11K 0.14% 128
2025
Q2
$338K Buy
1,212
+3
+0.2% +$850 0.16% 121
2025
Q1
$377K Sell
1,209
-42
-3% -$12.4K 0.19% 111
2024
Q4
$326K Buy
1,251
+24
+2% +$7.12K 0.16% 124
2024
Q3
$395K Sell
1,227
-35
-3% -$11.4K 0.2% 101
2024
Q2
$394K Buy
1,262
+3
+0.2% +$881 0.22% 93
2024
Q1
$358K Sell
1,259
-59
-4% -$17.3K 0.21% 100
2023
Q4
$380K Buy
1,318
+4
+0.3% +$1.09K 0.24% 85
2023
Q3
$353K Buy
1,314
+5
+0.4% +$1.25K 0.26% 80
2023
Q2
$291K Buy
1,309
+5
+0.4% +$1.16K 0.2% 104
2023
Q1
$315K Buy
1,304
+114
+10% +$28K 0.24% 95
2022
Q4
$313K Buy
1,190
+28
+2% +$7.51K 0.25% 94
2022
Q3
$262K Buy
1,162
+2
+0.2% +$485 0.23% 98
2022
Q2
$282K Buy
1,160
+3
+0.3% +$735 0.24% 89
2022
Q1
$280K Buy
1,157
+3
+0.3% +$689 0.19% 101
2021
Q4
$260K Buy
+1,154
New +$244K 0.17% 108

Other funds holding AMGN

O'Rourke & Company's AMGN Position: Q2 2026 in Review

O'Rourke & Company increased its Amgen (AMGN) stake by 0.25% in Q2 2026, buying an estimated $1.03K and bringing the position to 1,185 shares worth $429K. The position accounts for 0.15% of the portfolio, ranked #122.

O'Rourke & Company first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • O'Rourke & Company held 1,185 shares of Amgen worth $429K as of Q2 2026.
  • O'Rourke & Company bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.15% of O'Rourke & Company's portfolio in Q2 2026, its #122 holding.
  • O'Rourke & Company first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on O'Rourke & Company's 13F filing for Q2 2026, filed 14 Aug 2026.